Polycythemia vera is a rare form of blood cancer. Learn about the symptoms, causes, complications, diagnosis, treatment, prognosis, and life expectancy related to polycythemia vera.

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Secondary polycythemia, also known as secondary erythrocytosis or secondary erythrocythemia, is a rare condition in which your body produces an excess amount of red blood cells. This ...

Panelists discuss how rusfertide, a hepcidin mimetic peptide, shows promise in polycythemia vera by reducing phlebotomy ...

Just like any chronic health condition, polycythemia vera (PV) can have a negative impact on your everyday life. Research has shown that PV is associated with a lower quality of life in measures ...

THE course of polycythemia vera is complicated by hemorrhagic and thromboembolic phenomena of varying severity occurring in about a third of the cases. These complications have been ascribed to the ...

Polycythemia Vera. Cleveland Clinic. April 25, 2022. Jang A et al. Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients. Blood. November 5, 2020. Polycythemia Vera: Diagnosis ...

Researchers determined the presence of pulmonary hypertension was associated with worse outcomes for patients with polycythemia vera.

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.

Managing polycythemia vera (PV) is a delicate balance between controlling life-threatening clotting risks and preserving patients’ quality of life. 1 A review published in Clinical Lymphoma ...

Polycythemia has been reported in a number of patients with liver tumors of various kinds. 3–7 McFadzean and his associates 3,8 found elevated hemoglobin levels in about 10 to 12 per cent of ...